Altimmune (ALT)
Developing pemvidutide across MASH, AUD, and alcohol-associated liver disease.
$3.27
vs last close+0.00 (+0.00%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 44 days
EPS estimate
−$0.14
Revenue estimate
$1.8K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.33−$0.26−$0.27−$0.21−$0.27−$0.18−$0.12Pending
Estimate−$0.34−$0.35−$0.32−$0.29−$0.25−$0.25−$0.14−$0.14
Surprise+2.9%+25.7%+15.6%+27.6%−8.0%+28.0%+11.4%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$5.0K$5.0K$5.0K$5.0K$26.0K—$46.0KPending
Estimate$1.0K$560$1.4K$560$556$1.4K$2.0K$1.8K
Surprise+400.0%+792.9%+249.9%+792.9%+4,576.3%—+2,200.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.20 | — | — |
| Sep 2028 | −$0.20 | — | — |
| Jun 2028 | −$0.19 | — | — |
| Mar 2028 | −$0.19 | — | — |
| Dec 2027 | −$0.20 | — | — |
| Sep 2027 | −$0.19 | — | — |
| Jun 2027 | −$0.18 | — | — |
| Mar 2027 | −$0.17 | — | — |
| Dec 2026 | −$0.16 | — | — |
| Nov 2026 | −$0.14 | — | — |
| Aug 2026 | −$0.14 | −$0.12 | +11.4% |
| May 2026 | −$0.25 | −$0.18 | +28.0% |
| Mar 2026 | −$0.25 | −$0.27 | −8.0% |
| Nov 2025 | −$0.29 | −$0.21 | +27.6% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Apr 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.20 | — | — | $0 | — | — | — |
| Sep 2028 | −$0.20 | — | — | $0 | — | — | — |
| Jun 2028 | −$0.19 | — | — | $0 | — | — | — |
| Mar 2028 | −$0.19 | — | — | $0 | — | — | — |
| Dec 2027 | −$0.20 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.19 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.18 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.17 | — | — | $18.5M | — | — | — |
| Dec 2026 | −$0.16 | — | — | $1.8K | — | — | — |
| Nov 5, 2026 | −$0.14 | — | — | $1.8K | — | — | — |
| Aug 11, 2026 | −$0.14 | −$0.12 | +11.4% | $2.0K | $46.0K | +2,200.0% | −2.3% |
| May 13, 2026 | −$0.25 | −$0.18 | +28.0% | $1.4K | — | — | −2.0% |
| Mar 5, 2026 | −$0.25 | −$0.27 | −8.0% | $556 | $26.0K | +4,576.3% | −17.8% |
| Nov 6, 2025 | −$0.29 | −$0.21 | +27.6% | $560 | $5.0K | +792.9% | +5.1% |
| Aug 12, 2025 | |||||||
| May 13, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 27, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 15, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 17, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 11, 2020 | |||||||
| May 13, 2020 | |||||||
| Mar 27, 2020 | |||||||
| Nov 13, 2019 | |||||||
| Aug 13, 2019 | |||||||
| May 14, 2019 | |||||||
| Apr 1, 2019 | |||||||
| Nov 13, 2018 | |||||||
| Aug 14, 2018 | |||||||
| May 15, 2018 | |||||||
| Mar 28, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Aug 9, 2017 | |||||||
| May 3, 2017 | |||||||
| Mar 14, 2017 | |||||||
| Nov 4, 2016 | |||||||
| Aug 4, 2016 | |||||||
| May 9, 2016 | |||||||
| Mar 11, 2016 | |||||||
| Nov 6, 2015 | |||||||
| Aug 5, 2015 |